Anna Luisa Schaffgotsch

Anna Luisa Schaffgotsch has held a variety of roles in the technology and healthcare industries since 2010. In 2010, they held an internship at Blakpearl Ltd. Following this, they held an internship at HiPP-Gruppe in 2011, where they worked on research and development of product ranges and conducted and evaluated clinical trials. In 2014, they became an Account Manager at Fuerst Day Lawson, managing several important international key accounts in the food and beverage division. In 2015, they worked as a Business Development employee at Computomics, helping to set up the commercial team and bringing new services to the market. In 2016, they became an Account Executive at TraceLink, responsible for connecting the Life Sciences supply chain and eliminating counterfeit prescription drugs. In 2019, they held two roles simultaneously: Strategic Consultant/Director Sales at Medical iSight and Company Owner & Founder at Impli Limited. At Impli, they focus on HealthTech applications and monitoring/sensing solutions, while at Medical iSight they work to enable real-time 3D surgical navigation.

Anna Luisa Schaffgotsch has a diverse educational background. Anna Luisa completed a Master of Science (MSc) in Biotechnology from Imperial College London from 2012 to 2013. Prior to that, they earned a BSc (hon) in Nutrition and Food Sciences from the University of Nottingham from 2009 to 2012. Anna Luisa also completed a Pre Medical Course from Rheinisches Bildungs Zentrum Koeln from 2008 to 2009. Lastly, they earned an International Baccalaureate from Marymount International School London from 2006 to 2008, with a focus on Biology, Art, English, German, Economics, Maths, and Chemistry.